Stanford Medical Center finds a cure for a rare cancer

By Jennifer Tingley, Associated Press article Stanford Medical Centre researchers have found a cure that could save lives of thousands of people suffering from a rare type of cancer.

The new treatment could also help millions of other people in the United States who don’t have the disease, according to the team led by scientists at the university’s School of Medicine.

The treatment, known as a synthetic growth factor receptor (SGFR), works like a protein called an anti-cancer gene that inhibits the growth of tumor cells.

Scientists have found it’s possible to treat cancer with a new gene that’s produced by an animal.

That gene has been dubbed SGFR-G.

It can make it easier for cancer cells to invade the body.

But when cancer cells do invade, they can take over the body by using an entirely new mechanism to do so.

The team of scientists has discovered how to make the new gene from a protein known as SCF-1.

This protein acts like a transcription factor that regulates the cell’s DNA to stop the cell from dividing.

The SGFR gene can be produced by the animal itself, and it’s not produced in the human body.

It was discovered by a team led the University of California, San Francisco.

They’ve now tested the treatment in mice and human trials are under way in California and elsewhere.

The study is published in the journal Nature.

The research is the result of more than four years of research and collaboration between researchers at Stanford and the University at Buffalo.

They’ve been studying how the anti-growth factors produced by a virus attack cells that are in contact with them.

The virus can then cause the cells to turn into tumors.

Scientists are trying to figure out how the virus and the anti growth factors, together, can interfere with the cell cycle to make it hard for cells to grow.

The team has found that the anti gene is produced by SCF1, and the SGFR protein can be synthesized from the SCF gene.

The researchers hope to find a way to make SGFRs from animal stem cells, which are the main source of anti-tumor stem cells in the body, as well as human stem cells.

Researchers hope the new drug will be able to reverse the progression of cancer in mice by preventing tumor growth in the mice.

They believe it could also prevent other types of cancers from spreading to humans.

“We believe it’s a huge breakthrough in the treatment of this cancer,” said Dr. Michael C. Lappin, a professor of medicine at Stanford.

“The hope is that the treatment will be available in the clinic in less than a year.

That’s going to be very, very important.”

The research has been supported by the National Institutes of Health.

The University at Bills medical school is also supported by grants from the National Cancer Institute and the National Science Foundation.

Follow AP Science reporter Jennifer Tingsley on Twitter at @jennithingsley.